Position in SEPN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,095,623
+$13,892,142 QoQ
Shares Held
1,167,382
+11.3% QoQ
Ownership
2.50%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 154 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in SEPN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRIMECAP MANAGEMENT CO/CA/ holds $3,557,107,452 across 15 Biotechnology names. SEPN ranks #10 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
5,007,931 | $1,427,110,097 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
14,190,183 | $811,962,271 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
3,168,853 | $351,837,748 | |
| 4 | BNTX |
BioNTech SE
|
3,772,031 | $350,987,484 | |
| 5 | XNCR |
Xencor Inc
|
10,181,322 | $163,919,284 | |
| 6 | IMCR |
Immunocore Holdings plc
|
3,638,241 | $115,514,151 | |
| 7 | IMNM |
Immunome Inc.
|
4,581,431 | $97,080,522 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,015,980 | $75,670,190 |
All Filings in SEPN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,095,623 | 1,167,382 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,203,481 | 1,048,834 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $15,225,268 | 546,100 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||